Latest Breaking News On - Broad institute cas - Page 5 : comparemela.com

Editas Medicine to Present Clinical Data from the RUBY and

Company to host a webinar to discuss EDIT-301 clinical data on Monday, December 11, at 1:00 p.m. ET Dr. Rabi Hanna from Cleveland Clinic Children’s to.

San diego convention centerUnited statesUnited kingdomSan diegoBaisong meiRabi hannaHarvard university casAmerican society of hematology annual meetingAmerican society of hematologyBroad instituteDepartment of pediatric hematology oncologyEditas medicine incBroad institute casCleveland clinic childrenAmerican societyAnnual meeting

Editas Medicine Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EDIT-301 for the Treatment of Severe Sickle Cell Disease

CAMBRIDGE, Mass., Oct. 16, 2023 Editas Medicine, Inc. , a clinical-stage genome editing company, today announced that the U.S. Food and Drug Administration granted Regenerative Medicine.

United statesUnited kingdomGilmore oneillDrug administrationExchange commissionBroad institute casEditas medicine incHarvard university casBroad instituteRegenerative medicine advanced therapyChief executive officerCentury cures actOrphan drug designationRare pediatric diseaseEditas medicineHarvard university

Editas Medicine Strengthens Executive Leadership Team with Appointment of Caren Deardorf as Chief Commercial and Strategy Officer

CAMBRIDGE, Mass., Sept. 25, 2023 Editas Medicine, Inc. , a clinical-stage genome editing company, today announced the appointment of Caren Deardorf as the Company’s first Chief Commercial and.

United kingdomCaren deardorfOhana biosciencesGilmore oneillCrinetics pharmaceuticalsEditas medicine incProduct development commercializationBroad instituteDana farber center instituteBroad institute casMaster of business administrationHarvard university casLeadership teamExchange commissionTufts universityChief commercial

Editas Medicine Reports Inducement Grants to New Chief Commercial and Strategy Officer

CAMBRIDGE, Mass., Sept. 25, 2023 Editas Medicine, Inc. , a clinical-stage genome editing company, today announced the grant of an inducement award to the Company’s newly appointed Chief.

United kingdomCaren deardorfEditas medicine incBroad institute casHarvard university casBroad instituteChief commercialStrategy officerEditas medicine boardEditas medicineNasdaq listing ruleHarvard university

Editas Medicine Reports Inducement Grants to New Chief Commercial and Strategy Officer

Editas Medicine Reports Inducement Grants to New Chief Commercial and Strategy Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomCristi barnettCaren deardorfBroad institute casBroad instituteHarvard university casEditas medicine incMedicine reports inducement grantsNew chief commercialChief commercialStrategy officerEditas medicine boardEditas medicineNasdaq listing ruleHarvard universityInvestor contact